Detalhe da pesquisa
1.
Lurbinectedin in small cell lung cancer: real-world experience of a multicentre national early access programme.
Intern Med J
; 2024 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38369719
2.
A phase 1 safety and bioimaging trial of antibody DS-8895a against EphA2 in patients with advanced or metastatic EphA2 positive cancers.
Invest New Drugs
; 40(4): 747-755, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35404015
3.
Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic review.
J Neurooncol
; 159(3): 539-549, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35933567
4.
Current Development of Monoclonal Antibodies in Cancer Therapy.
Recent Results Cancer Res
; 214: 1-70, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31473848
5.
Antibody-Drug Conjugates for Cancer Therapy.
Molecules
; 25(20)2020 Oct 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33081383
6.
Delayed Autoimmune Toxicity Occurring Several Months After Cessation of Anti-PD-1 Therapy.
Oncologist
; 23(7): 849-851, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29666298
7.
Novel Approaches To Undergraduate Oncology Education.
J Cancer Educ
; 33(3): 500-504, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27581433
8.
Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases.
Br J Cancer
; 116(12): 1558-1563, 2017 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28524161
9.
Correction to: Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic review.
J Neurooncol
; 159(3): 551, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35994157
10.
Lung cancer in non-smokers: a diagnosis of increasing importance.
Med J Aust
; 216(7): 342-343, 2022 04 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35323996
11.
Late presentation of generalised bullous pemphigoid-like reaction in a patient treated with pembrolizumab for metastatic melanoma.
Australas J Dermatol
; 58(3): e109-e112, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27170423
12.
Implementation of a nurse-led, multidisciplinary model of care for older adults with cancer: a process evaluation protocol.
BMJ Open
; 14(1): e077005, 2024 01 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38296284
13.
A Phase II trial of alternating osimertinib and gefitinib therapy in advanced EGFR-T790M positive non-small cell lung cancer: OSCILLATE.
Nat Commun
; 15(1): 1823, 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38418463
14.
Real-world challenges in undertaking NTRK fusion testing in non-small cell lung cancer.
J Thorac Dis
; 15(7): 3811-3817, 2023 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37559603
15.
Real-World Analysis of Clinical Characteristics and Survival Outcomes in Patients With Extensive-Stage SCLC Treated With First-Line Chemoimmunotherapy.
JTO Clin Res Rep
; 4(8): 100544, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37529402
16.
Antibody drug conjugates for glioblastoma: current progress towards clinical use.
Expert Opin Biol Ther
; 23(11): 1089-1102, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37955063
17.
LOREALAUS: LOrlatinib REAL-World AUStralian Experience in Advanced ALK-Rearranged NSCLC.
JTO Clin Res Rep
; 4(4): 100490, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37077199
18.
Reply to 'Comment on 'Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy''.
Br J Cancer
; 116(8): e15, 2017 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28324885
19.
Radiolabeled Antibodies for Cancer Imaging and Therapy.
Cancers (Basel)
; 14(6)2022 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35326605
20.
Antibody-drug conjugates: beyond current approvals and potential future strategies.
Explor Target Antitumor Ther
; 3(2): 252-277, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36046842